Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medications in U.S.-approved clinical trials to treat this inflammatory process.
advertisement
Treatments for Cardiac Blood Vessel Inflammation In the Works
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medications in U.S.-approved clinical trials to treat this inflammatory process.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?